Z
Zongyi Hu
Researcher at National Institutes of Health
Publications - 28
Citations - 1734
Zongyi Hu is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Hepatitis C virus & Viral replication. The author has an hindex of 14, co-authored 24 publications receiving 1590 citations.
Papers
More filters
Journal ArticleDOI
A genome-wide genetic screen for host factors required for hepatitis C virus propagation
Qisheng Li,Abraham L. Brass,Aylwin Ng,Zongyi Hu,Ramnik J. Xavier,T. Jake Liang,Stephen J. Elledge +6 more
TL;DR: A genome-wide small interfering RNA (siRNA) screen using an infectious HCV cell culture system was completed and candidate genes found included known or previously identified factors, and also implicate many additional host cell proteins in HCV infection.
Journal ArticleDOI
Hepatitis B Virus X Protein Is both a Substrate and a Potential Inhibitor of the Proteasome Complex
TL;DR: An association in vivo of HBX with the 26S proteasome complex is demonstrated by coimmunoprecipitation and colocalization upon sucrose gradient centrifugation and blocked the transactivation by HBX.
Journal ArticleDOI
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees
Gamal A. Elmowalid,Ming Qiao,Sook Hyang Jeong,Brian B. Borg,Thomas F. Baumert,Ronda K. Sapp,Zongyi Hu,Krishna K. Murthy,T. Jake Liang +8 more
TL;DR: It is suggested that HCV-LP immunization inducesHCV-specific cellular immune responses that can control HCV challenge in the chimpanzee model.
Journal ArticleDOI
Ribavirin potentiates interferon action by augmenting interferon‐stimulated gene induction in hepatitis C virus cell culture models
Emmanuel Thomas,Jordan J. Feld,Jordan J. Feld,Qisheng Li,Zongyi Hu,Michael W. Fried,T. Jake Liang +6 more
TL;DR: The study suggests that ribavirin, acting by way of a novel innate mechanism, potentiates the anti‐HCV effect of IFN.
Journal ArticleDOI
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
Shanshan He,Billy Lin,Virginia Chu,Zongyi Hu,Xin Hu,Jingbo Xiao,Amy Wang,Cameron J. Schweitzer,Qisheng Li,Michio Imamura,Nobuhiko Hiraga,Noel Southall,Marc Ferrer,Wei Zheng,Kazuaki Chayama,Juan J. Marugan,T. Jake Liang +16 more
TL;DR: Chlorcyclizine HCl (CCZ), an over-the-counter drug for allergy symptoms, is identified and characterized as an anti-HCV drug in vitro and in vivo, and represents a promising candidate for drug repurposing and further development as an effective and accessible agent for treatment of HCV infection.